MAY 26, 2019 6:21 PM PDT

A Test to Measure the Effectiveness of Stem Cell Transplantation

WRITTEN BY: Carmen Leitch

Stem cells are like a blank slate, and researchers have imagined using them to fill in for damaged cells that cause disease. Many disorders, like type II diabetes, or Parkinson's, might one day be treatable with stem cell-based therapies, and scientists are working on creating such therapeutics. These treatments will have to be assessed for safety and efficacy. Now a team of scientists has developed a repeatable, non-invasive, timely technique to know if transplanted stem cells are repairing damaged heart tissue. The work has been reported in Science Translational Medicine and is outlined in the video.

The research team, made up of investigators from the University of Maryland School of Medicine (UMSOM), University of Pennsylvania, and Emory University aimed to create a way to analyze exosomes in blood. Exosomes are small compartments that are released from most cell types. They were once thought of as a waste disposal system, but they may also be a way for cells to send signals and can contain many types of biological molecules. 

In this work, the researchers assessed exosomes in rats that modeled stem cell transplantation after myocardial infarction, or heart attack. Circulating exosomes were found to carry cell parts to the muscle cells targeted in the heart, and resulted in repair of the cardiac tissue. 

"Exosomes contain the signals of the cells they're derived from - proteins as well as nucleic acids and micro ribonucleic acids (miRNAs) - which affect receptor cells and remodel or regenerate the organ we're targeting," explained study co-senior author Sunjay Kaushal, Ph.D., MD, Professor of Surgery at UMSOM and Director of Pediatric Cardiac Surgery at the University of Maryland Children's Hospital. "We now have a tool to determine whether stem cell therapy will be efficacious for an individual patient, not only for the heart but for any organ that received stem cell therapy."

The scientists called their blood test a "liquid biopsy," and they used it with a rat model in which human cardiosphere-derived cells (CDCs) and cardiac progenitor cells (CPCs) were transplanted into hearts after myocardial infarction. After seven days, the level of exosomes in blood plasma was measured. Next, the team purified the exosomes from the CDCs and CPCs and determined that they carried miRNAs linked to heart muscle recovery.

CPCs and CDCs the were grown in the lab were found to carry different stuff than the ones from cells transplanted in the rodent model.

"Our study should be considered the first stepping stone in understanding what stem cells do, but an important point is that the cells we identified as responding changed their gene expression, behavior, and secretions," said co-lead author Sudhish Sharma, Ph.D., UMSOM Assistant Professor of Surgery. "By using these biomarkers, we can understand the mechanism and extent of recovery."

 

Sources: AAAS/Eurekalert! via University of Maryland Medical Center, Science Translational Medicine

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 27, 2022
Neuroscience
How the Lactate Receptor is Related to Brain Injury in Newborns
SEP 27, 2022
How the Lactate Receptor is Related to Brain Injury in Newborns
Hypoxic-ischemic brain injury, which occurs when the brain's supply of oxygen and blood is blocked for a period of time, ...
SEP 29, 2022
Cancer
Customer-Led Innovation: Building the CTS Xenon
SEP 29, 2022
Customer-Led Innovation: Building the CTS Xenon
How customers and R&D scientists came together across oceans and a pandemic to create a next-gen cell therapy soluti ...
OCT 14, 2022
Drug Discovery & Development
Experimental Gene Therapy Restores Night Vision in Blind Patients
OCT 14, 2022
Experimental Gene Therapy Restores Night Vision in Blind Patients
Adults with a hereditary form of childhood-onset blindness experienced dramatic improvements in night vision within days ...
OCT 31, 2022
Genetics & Genomics
Ancient Viral DNA in Our Genome Has a Protective Function
OCT 31, 2022
Ancient Viral DNA in Our Genome Has a Protective Function
There is viral DNA in the human genome, and each instance traces back to an ancestor who was infected with a retrovirus. ...
NOV 08, 2022
Drug Discovery & Development
Blood Pressure Drug May Reduce Alzheimer's Risk in Black People
NOV 08, 2022
Blood Pressure Drug May Reduce Alzheimer's Risk in Black People
Telmisartan, a blood pressure-lowering medication, may help prevent or treat Alzheimer's disease (AD) in Black indiv ...
DEC 05, 2022
Drug Discovery & Development
Characterization and Manufacturing of AAVs for Gene Therapy
DEC 05, 2022
Characterization and Manufacturing of AAVs for Gene Therapy
The backdrop upon which every successful gene therapy is developed is the ability to safely and specifically target cell ...
Loading Comments...